持股变动声明
Nephros(NEPH)03-15 04:35
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001048462-24-000011 Size: 6 KB 网页链接
简介:Nephros, Inc.于1997年4月3日根据特拉华州法律注册成立。该公司是一家商业级公司,为医疗器械和商业市场开发和销售高性能水净化产品。在医疗器械市场, 他们的过滤器,通常被归类为超滤器,主要由医院用于预防水传播病原体感染。在商业市场,该公司生产和销售改善水的味道和气味并减少生物膜,细菌和规模的过滤器 在下游设备中积聚。
今开:2.22 | 昨收:2.19 |
最高:2.31 | 最低:2.155 |
涨停价: | 跌停价: |
总市值:23091664 |
Nephros(NEPH)03-15 04:35
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001048462-24-000011 Size: 6 KB 网页链接
Nephros(NEPH)04-13 04:05
$Nephros(NEPH)$ DEF 14A Other definitive proxy statements Accession Number: 0001493152-24-014442 Act: 34 Size: 1 MB 网页链接
Nephros(NEPH)03-15 04:45
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001048462-24-000012 Size: 12 KB 网页链接
Nephros(NEPH)03-16 04:35
$Nephros(NEPH)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001493152-24-010107 Act: 34 Size: 7 MB 网页链接
Nephros(NEPH)03-08 05:25
$Nephros(NEPH)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-24-009216 Act: 34 Size: 345 KB 网页链接
Nephros(NEPH)04-13 04:15
$Nephros(NEPH)$ ARS Annual Report to Security Holders Accession Number: 0001493152-24-014448 Act: 34 Size: 1 MB 网页链接
Nephros(NEPH)04-13 04:15
$Nephros(NEPH)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001493152-24-014447 Act: 34 Size: 709 KB 网页链接
蹊之美股生物医药2021-07-09 20:55
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Aerpio Pharm (ARPO) +63.16%
GBS Inc (GBS) +33.22%
Alterity Therapeutics (ATHE) +27.85%
9 Meters Biopharma (NMTR) +20.39%
F-star Therapeutics (FSTX) +9.13%
Los...查看全文
$Nephros(NEPH)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001493152-24-014447 Act: 34 Size: 709 KB 网页链接
$Nephros(NEPH)$ ARS Annual Report to Security Holders Accession Number: 0001493152-24-014448 Act: 34 Size: 1 MB 网页链接
$Nephros(NEPH)$ DEF 14A Other definitive proxy statements Accession Number: 0001493152-24-014442 Act: 34 Size: 1 MB 网页链接
$Nephros(NEPH)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001493152-24-010107 Act: 34 Size: 7 MB 网页链接
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001048462-24-000012 Size: 12 KB 网页链接
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001048462-24-000011 Size: 6 KB 网页链接
$Nephros(NEPH)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-24-009216 Act: 34 Size: 345 KB 网页链接
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-23-022642 Size: 4 KB 网页链接
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-23-022644 Size: 11 KB 网页链接
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-23-022643 Size: 7 KB 网页链接